Download FREE Report Sample
Download Free sampleHuman Single-cell multi-omics can analyze genome, epigenome, transcriptome, proteome, and metabolome lineages, unlike live-cell fluorescence imaging, which is a method of destroying cells for analysis.
Human Single-Cell Multi-Omics Market contains market size and forecasts of Human Single-Cell Multi-Omics in Global, including the following market information:
Global Human Single-Cell Multi-Omics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Human Single-Cell Multi-Omics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Single-Cell Transcriptomics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Single-Cell Multi-Omics include 10x Genomics, 1CellBio, BGI Genomics, Bio-Rad Laboratories, Celsee, Fluidigm Corporation, Fluxion Biosciences, MissionBio and NanoString Technologies and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Human Single-Cell Multi-Omics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Single-Cell Multi-Omics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Human Single-Cell Multi-Omics Market Segment Percentages, by Type, 2021 (%)
Single-Cell Transcriptomics
Single-Cell Genomics
Single-Cell Proteomics
Global Human Single-Cell Multi-Omics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Human Single-Cell Multi-Omics Market Segment Percentages, by Application, 2021 (%)
Clinical Research
Translational Research
Synthetic Biology
Global Human Single-Cell Multi-Omics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Human Single-Cell Multi-Omics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Single-Cell Multi-Omics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Human Single-Cell Multi-Omics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
1CellBio
BGI Genomics
Bio-Rad Laboratories
Celsee
Fluidigm Corporation
Fluxion Biosciences
MissionBio
NanoString Technologies
Takara Bio
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy